Eisai looks to its acquisitions for growth
This article was originally published in Scrip
Executive Summary
Eisai expects its US sales to reach $4 billion in fiscal 2009 (beginning April 1st), two years ahead of its original plan and boosted by the acquisition of the oncology company MGI Pharma.